AU Patent

AU2015202884A1 — Oral formulations of cytidine analogs and methods of use thereof

Assigned to Celgene Corp · Expires 2015-06-18 · 11y expired

What this patent protects

A method for treating a solid tumour comprising orally administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of 5 5 azacytidine, wherein the composition is a non-enteric coated tablet.

USPTO Abstract

A method for treating a solid tumour comprising orally administering to a subject in need thereof a pharmaceutical composition comprising a therapeutically effective amount of 5 5 azacytidine, wherein the composition is a non-enteric coated tablet.

Drugs covered by this patent

Patent Metadata

Patent number
AU2015202884A1
Jurisdiction
AU
Classification
—
Expires
2015-06-18
Drug substance claim
No
Drug product claim
No
Assignee
Celgene Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.